In a win for Re­gen­eron, No­var­tis' sy­ringe for AMD drug de­clared 'un­patentable'

Re­gen­eron has won a patent case against Swiss phar­ma gi­ant No­var­tis over the de­liv­ery sys­tem for its eye drug Eylea.

The US Patent Tri­al and …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Director of IT, Security

Viridian Therapeutics

Waltham, MA, USA